查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1794715

全球肉瘤切片檢查市場

Sarcoma Biopsy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球肉瘤切片檢查市場規模將達到 2.558 億美元

全球肉瘤切片檢查市場規模預計在2024年為2.295億美元，預計到2030年將達到2.558億美元，在2024-2030年的分析期內，複合年成長率為1.8%。可重複使用的肉瘤切片檢查設備是本報告分析的細分市場之一，預計其複合年成長率為1.4%，到分析期結束時將達到1.625億美元。一次性肉瘤切片檢查設備細分市場在分析期間的複合年成長率估計為2.6%。

美國市場規模估計為 6,250 萬美元，中國市場預計複合年成長率為 3.6%

美國肉瘤切片檢查市場規模預計在2024年達到6,250萬美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到4,760萬美元，在2024-2030年的分析期間內，複合年成長率為3.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為0.6%和1.3%。在歐洲，預計德國的複合年成長率約為0.9%。

全球肉瘤切片檢查市場—主要趨勢和促進因素摘要

為什麼準確的切片檢查對於肉瘤亞型的管理很重要？

肉瘤是一類源自間葉組織的罕見異質性惡性腫瘤，需要準確的組織病理學診斷指南治療計劃和預後評估。肉瘤有超過70種不同的亞型，包括骨癌、脂肪肉瘤、平滑肌肉瘤和滑膜肉瘤。準確的切片檢查是區分良性病變和侵襲性惡性腫瘤的基礎。細針抽吸 (FNA)、粗針穿刺切片(CNB) 和開放性手術切片檢查是主要方法，每種方法的選擇均基於腫瘤位置、大小和可疑病理學觀察。其中，影像引導下芯針活體組織切片是初步診斷的首選方法，因為它能夠獲得足夠的組織樣本，且併發症發生率較低。

切片檢查技術的選擇直接影響診斷結果、分期準確度和個人化治療的可能性。不恰當的切片檢查，尤其是在缺乏多學科評審的情況下，可能導致腫瘤擴散、分級不準確和手術切緣受損。肉瘤專科中心現在要求在骨科腫瘤科醫生和放射科醫生的監督下進行切片檢查，以確保最佳的樣本採集、軌跡規劃和切片檢查後手術的可行性。由於許多肉瘤存在影響治療決策的不同基因融合和突變（例如 EWSR1、SYT-SSX），因此切片檢查對於分子和細胞遺傳學檢測的重要性也日益增加。因此，切片檢查過程擴大被整合到診斷精準度和次世代定序儀工作流程中。

哪些創新將提高肉瘤切片檢查的準確性和效用？

影像學和分子診斷技術的進步正在改變肉瘤切片檢查的實施、解讀和臨床決策應用方式。 MRI 和 CT 等高解析度影像設備的廣泛應用，使得更精準地定位腫瘤活體組織切片區域，同時避免壞死和纖維化組織。超音波導引下穿刺活體組織切片 (CNB) 因其即時視覺化和操作效率，在表淺和軟組織肉瘤的診斷中越來越受歡迎。對於深層腫瘤，通常採用 CT 引導或螢光透視引導下的切片檢查，以提高診斷率並最大限度地減少併發症。

數位病理學和人工智慧輔助組織解讀的興起正在加速診斷的速度和準確性。這些平台能夠快速進行數位切片分析、模式識別，並實現與肉瘤專家的即時會診。此外，螢光原位雜合反應(FISH)、逆轉錄-聚合酵素鏈鎖反應(RT-PCR) 和次世代定序(NGS) 等分子檢測技術正擴大應用於切片檢查檢體，以識別致癌融合、易位和可操作突變。液體螢光在肉瘤治療中尚處於起步階段，但作為一種非侵入性方法，液態切片正在研究用於補充組織切片檢查，以進行病情監測和微量殘存疾病檢測。這些技術正在推動肉瘤治療朝向更個人化、以生物標記主導的方向發展。

哪些臨床環境和地理位置會影響肉瘤切片檢查實踐？

肉瘤切片檢查主要在擁有專業腫瘤科、病理科和外科團隊的三級轉診中心進行。這些中心配備了高精度影像引導切片檢查設備，並整合了分子病理學服務，以進行全面的診斷分析。在北美和西歐，集中式肉瘤網路按照規範的工作流程進行切片檢查，以最大限度地減少診斷錯誤並最大程度地協調治療。美國、英國、英國、德國和荷蘭是重要的中心，這些中心的切片檢查計劃由腫瘤委員會內的多學科團隊制定，以確保診斷和治療策略的一致性。

在新興市場，切片檢查實踐因醫療基礎設施和腫瘤專家的可及性而異。雖然影像引導下活體組織切片在都市區越來越普及，但農村醫院通常依賴手術切除進行診斷，這增加了操作風險並延誤了治療。然而，腫瘤治療的分散化和影像設備的投資正在逐步提高切片檢查的可及性。病患態度、醫療資金和轉診途徑也影響切片檢查利用率的地區差異。亞太市場，尤其是日本、韓國和印度，分子診斷的整合度正在提高，而拉丁美洲和中東地區則透過與國際癌症網路和非政府組織的合作實現了成長。

哪些因素推動了全球肉瘤切片檢查市場的成長？

肉瘤切片檢查市場的成長受到多種相互關聯的因素驅動，包括罕見和複雜肉瘤發病率的上升、診斷成像技術的進步以及精準腫瘤學的日益普及。早期準確的診斷是有效治療肉瘤的基石，而切片檢查是通往標靶治療和手術計劃的途徑。對多學科護理和集中式腫瘤管理的​​日益重視，推動著切片檢查程序在臨床前瞻性指導下進行，並被整合到更廣泛的腫瘤治療路徑中。影像技術、切片穿刺針設計和分子檢測技術的進步正在提高診斷產量比率、患者安全性和周轉時間。

癌症意識的提升、醫療基礎設施的擴張以及肉瘤登記數量的激增，也推動了對切片檢查服務的需求。切片檢查樣本的效用正從組織學擴展到基因組學、蛋白質組學和免疫表現型分析，為病理實驗室和診斷設備製造商創造新的價值流。對罕見癌症研究的監管支持，以及對肉瘤臨床試驗的投入增加，進一步刺激了市場發展。此外，針對放射科醫生和病理科醫生的培訓計劃正在提高資源匱乏地區的診療能力。綜上所述，這些趨勢正在強化切片檢查作為肉瘤診療發展中關鍵診斷手段的作用。

部分

產品類型（可重複使用肉瘤切片檢查設備、一次性肉瘤切片檢查設備）、最終用戶（醫院最終用戶、門診手術中心最終用戶、診斷中心最終用戶）

受訪公司範例

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ANGLE plc
  • Argon Medical Devices
  • Becton, Dickinson and Company（BD）
  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical Incorporated
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • Medtronic plc
  • Myriad Genetics, Inc.
  • QIAGEN NV
  • Siemens Healthineers
  • Sterylab Srl
  • Thermo Fisher Scientific Inc.
  • UROMED

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP37968

Global Sarcoma Biopsy Market to Reach US$255.8 Million by 2030

The global market for Sarcoma Biopsy estimated at US$229.5 Million in the year 2024, is expected to reach US$255.8 Million by 2030, growing at a CAGR of 1.8% over the analysis period 2024-2030. Reusable Sarcoma Biopsy Devices, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$162.5 Million by the end of the analysis period. Growth in the Disposable Sarcoma Biopsy Devices segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$62.5 Million While China is Forecast to Grow at 3.6% CAGR

The Sarcoma Biopsy market in the U.S. is estimated at US$62.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$47.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.9% CAGR.

Global Sarcoma Biopsy Market - Key Trends & Drivers Summarized

Why Is Accurate Biopsy Critical in the Management of Sarcoma Subtypes?

Sarcomas, a heterogeneous group of rare malignant tumors arising from mesenchymal tissues, demand precise histopathological diagnosis to guide treatment planning and prognostic assessment. With over 70 distinct subtypes-including osteosarcoma, liposarcoma, leiomyosarcoma, and synovial sarcoma-accurate biopsy is fundamental to differentiating benign lesions from aggressive malignancies. Fine-needle aspiration (FNA), core needle biopsy (CNB), and open surgical biopsies are the primary methods used, each selected based on tumor location, size, and suspected pathology. Among these, image-guided CNB has become the preferred modality for initial diagnosis due to its ability to retrieve sufficient tissue samples with minimal morbidity.

The choice of biopsy technique directly influences diagnostic yield, staging accuracy, and the feasibility of personalized treatment. Biopsies that are improperly performed-particularly without multidisciplinary input-can lead to tumor seeding, inaccurate grading, or compromised resection margins. Specialized sarcoma centers now mandate biopsy under the supervision of oncologic orthopedic surgeons and radiologists to ensure optimal sample collection, trajectory planning, and post-biopsy surgical feasibility. The importance of biopsy in molecular and cytogenetic testing is also increasing, as many sarcomas harbor distinct gene fusions or mutations (e.g., EWSR1, SYT-SSX) that impact therapeutic decisions. As a result, the biopsy process is becoming more integrated with precision diagnostics and next-generation sequencing workflows.

What Technological Innovations Are Advancing the Accuracy and Utility of Sarcoma Biopsies?

Technological advancements in imaging and molecular diagnostics are transforming the way sarcoma biopsies are performed, interpreted, and utilized for clinical decision-making. The widespread use of high-resolution imaging modalities-such as MRI and CT-enables more accurate targeting of viable tumor regions while avoiding necrotic or fibrotic tissue. Ultrasound-guided CNB, in particular, is gaining favor for superficial and soft-tissue sarcomas due to real-time visualization and procedural efficiency. In deep-seated tumors, CT-guided or fluoroscopy-assisted biopsy is often employed to improve diagnostic yield and minimize complications.

The rise of digital pathology and AI-assisted histological interpretation is accelerating the speed and precision of diagnosis. These platforms enable rapid digital slide analysis, pattern recognition, and real-time consultation with sarcoma specialists. Additionally, molecular assays-such as fluorescence in situ hybridization (FISH), reverse transcription polymerase chain reaction (RT-PCR), and next-generation sequencing (NGS)-are increasingly performed on biopsy specimens to identify oncogenic fusions, translocations, and actionable mutations. Liquid biopsy, though still in its early stages for sarcomas, is being explored as a non-invasive complement to tissue biopsy for disease monitoring and minimal residual disease detection. These technological enablers are facilitating a shift toward more individualized and biomarker-driven sarcoma treatment pathways.

Which Clinical Settings and Geographies Are Shaping Sarcoma Biopsy Practices?

Sarcoma biopsies are predominantly conducted in tertiary referral centers with dedicated oncology, pathology, and surgical teams. These centers are equipped to perform high-precision, image-guided biopsies and integrate molecular pathology services for comprehensive diagnostic profiling. In North America and Western Europe, centralized sarcoma networks ensure that biopsies are performed under protocolized workflows, minimizing diagnostic errors and maximizing treatment coordination. The U.S., U.K., France, Germany, and the Netherlands are key hubs where multidisciplinary teams conduct biopsy planning within tumor boards, ensuring alignment between diagnostic strategy and therapeutic trajectory.

In emerging economies, biopsy practices vary based on healthcare infrastructure and access to oncologic expertise. While image-guided CNB is increasingly available in urban centers, rural hospitals often rely on surgical excision for diagnostic purposes, increasing procedural risks and delaying treatment. However, initiatives to decentralize oncology services and invest in diagnostic imaging equipment are gradually improving biopsy accessibility. Regional disparities in biopsy utilization are also shaped by patient awareness, healthcare funding, and referral pathways. Asia-Pacific markets, particularly Japan, South Korea, and India, are making strides in molecular diagnostic integration, while Latin America and the Middle East are seeing growth through partnerships with international cancer networks and NGOs.

What Factors Are Driving Growth in the Global Sarcoma Biopsy Market?

The growth in the sarcoma biopsy market is driven by several interrelated factors, including the increasing incidence of rare and complex sarcomas, advancements in diagnostic imaging, and the rising adoption of precision oncology. Early and accurate diagnosis remains the cornerstone of effective sarcoma treatment, with biopsy serving as the gateway to targeted therapy and surgical planning. The growing emphasis on multidisciplinary care and centralized tumor management is ensuring that biopsy procedures are performed with clinical foresight and integrated into broader oncology pathways. Technological improvements in imaging, biopsy needle design, and molecular testing are improving diagnostic yield, patient safety, and turnaround times.

Rising cancer awareness, expanding healthcare infrastructure, and the proliferation of sarcoma registries are also accelerating demand for biopsy services. Biopsy sample utility has extended beyond histology to encompass genomics, proteomics, and immunophenotyping, creating new value streams for pathology labs and diagnostic device manufacturers. Regulatory support for rare cancer research, along with increased investment in sarcoma-focused clinical trials, is further boosting market activity. Additionally, training initiatives aimed at radiologists and pathologists are building capacity in under-resourced settings. Collectively, these dynamics are reinforcing the role of biopsy as a diagnostic linchpin in the evolving landscape of sarcoma care.

SCOPE OF STUDY:

The report analyzes the Sarcoma Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reusable Sarcoma Biopsy Devices, Disposable Sarcoma Biopsy Devices); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ANGLE plc
  • Argon Medical Devices
  • Becton, Dickinson and Company (BD)
  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical Incorporated
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • Medtronic plc
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers
  • Sterylab S.r.l.
  • Thermo Fisher Scientific Inc.
  • UROMED

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Sarcoma Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Soft Tissue and Bone Sarcomas Spurs Growth in Biopsy-Based Diagnostics
    • Increased Emphasis on Early and Accurate Diagnosis Strengthens Business Case for Advanced Biopsy Methods
    • Growth in Image-Guided Biopsy Techniques Enhances Precision and Diagnostic Yield in Sarcoma Cases
    • Adoption of Minimally Invasive Biopsy Approaches Expands Patient Comfort and Compliance
    • Expansion of Tumor Genotyping and Molecular Profiling Drives Demand for High-Quality Biopsy Samples
    • Integration of Liquid Biopsy and Circulating Tumor DNA Analysis Expands Non-Invasive Diagnostic Options
    • Clinical Need for Histopathological Subtyping Fuels Demand for Core Needle and Open Biopsies
    • Rising Awareness of Misdiagnosis in Rare Sarcoma Subtypes Propels Demand for Biopsy Re-Evaluation
    • Growth in Multidisciplinary Sarcoma Centers Strengthens Standardization of Biopsy Protocols
    • Advances in Biomarker Discovery and Tissue Analysis Enhance Biopsy-Driven Research
    • Increasing Demand for Biobanked Sarcoma Tissue Expands Role of Biopsy in Translational Medicine
    • Development of AI-Based Histology Interpretation Tools Accelerates Biopsy Result Turnaround
    • Growth in Personalized Oncology and Targeted Therapies Drives Re-Biopsy at Progression or Recurrence
    • Surge in Clinical Trials for Rare Sarcomas Generates Consistent Demand for Diagnostic Tissue Acquisition
    • Integration of Molecular Pathology in Biopsy Analysis Expands Scope Beyond Morphology
    • Digital Workflow and Cloud-Based Pathology Tools Improve Biopsy Sample Sharing Across Institutions
    • Expansion of Multisite Hospital Networks Fuels Centralized Biopsy Services for Sarcoma Diagnosis
    • Collaborations Between Academic Hospitals and Oncology Biotech Firms Enhance Sample Access
    • Regulatory Push for Diagnostic Standardization in Oncology Improves Biopsy Reporting Quality
    • Increased Emphasis on Quality Control and Accreditation of Biopsy Labs Drives Institutional Investment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sarcoma Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sarcoma Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reusable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reusable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Reusable Sarcoma Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disposable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Disposable Sarcoma Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Sarcoma Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Sarcoma Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Sarcoma Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Sarcoma Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION